Experimental rhinovirus 16 infection increases intercellular adhesion molecule‐1 expression in bronchial epithelium of asthmatics regardless of inhaled steroid treatment
- 1 July 2000
- journal article
- clinical trial
- Published by Wiley in Clinical and Experimental Allergy
- Vol. 30 (7) , 1015-1023
- https://doi.org/10.1046/j.1365-2222.2000.00854.x
Abstract
Background: Rhinovirus infections in airway epithelial cells in vitro have been shown to upregulate intercellular adhesion molecule‐1 (ICAM‐1) expression. Epithelial ICAM‐1, in its dual role as the major rhinovirus receptor and as adhesion molecule for inflammatory cells may be involved in the pathogenesis of rhinovirus‐induced exacerbations of asthma.Objective: We aimed to investigate the effect of experimental rhinovirus 16 (RV16) infection on ICAM‐1 expression in bronchial mucosal biopsies in asthma. In addition, the effect of 2 weeks pretreatment with inhaled budesonide (800 μg b.d.) on RV16‐associated changes in ICAM‐1 expression was studied.Methods: The study had a parallel, placebo‐controlled design in 25 steroid‐naive nonsmoking atopic asthmatic subjects. After 2 weeks budesonide (BUD) or placebo (PLAC) pretreatment bronchoscopy was performed 2 days before (day −2) and 6 days after (day 6) RV16 inoculation (on days 0 and 1). Immunohistochemical staining for ICAM‐1 was performed on snap‐frozen bronchial biopsies. ICAM‐1 staining intensity on the basal epithelial cells was scored semiquantitatively from 1 (weak) to 3 (intense). Similarly, epithelial intactness was noted (1 = basal cells only, 2 = basal and parabasal cells, 3 = intact epithelium).Results: ICAM‐1 scores were not significantly different between the groups at day −2 (P ≥ 0.08). Subsequent RV16 infection was associated with a trend towards an increase in ICAM‐1 expression in the BUD‐group (P = 0.07), whereas the increase was significant in the PLAC‐group (P = 0.03). However, the increase was not significantly different between the groups (P = 0.74). Epithelial intactness score was not different between the groups before RV16 infection (P ≥ 0.07), and no significant changes were observed in either group (P ≥ 0.59). Moreover, ICAM‐1 score did not correlate significantly with epithelium score in either group, at any time‐point (P ≥ 0.27).Conclusion: We conclude that an RV16 common cold in atopic asthmatic subjects is associated with increased ICAM‐1 expression in the bronchial epithelium, which is not related to epithelial intactness. Glucocorticoid treatment does not appear to prevent the RV16‐associated increased ICAM‐1 expression. This suggests that other treatment modalities are required to protect against the spreading of infection during rhinovirus‐induced exacerbations in asthma.Keywords
This publication has 32 references indexed in Scilit:
- Hyperoxic Increases in Lung ICAM-1 mRNA are Independent of TNF-α and IL-1β mRNAFree Radical Biology & Medicine, 1997
- Inhibition of adhesion molecules by budesonide on a human epithelial cell line (lung carcinoma)Allergy, 1997
- The biology of PECAM-1.Journal of Clinical Investigation, 1997
- Bronchial biopsies and airway inflammationEuropean Respiratory Journal, 1996
- Rhinovirus stimulation of interleukin-6 in vivo and in vitro. Evidence for nuclear factor kappa B-dependent transcriptional activation.Journal of Clinical Investigation, 1996
- Increased Levels of Interleukin-1 Are Detected in Nasal Secretions of Volunteers during Experimental Rhinovirus ColdsThe Journal of Infectious Diseases, 1994
- Expression of endothelial and leukocyte adhesion molecules intercellular adhesion molecule-1, E-selectin, and vascular cell adhesion molecule-1 in the bronchial mucosa in steady-state and allergen-induced asthmaJournal of Allergy and Clinical Immunology, 1993
- Intercellular Adhesion Molecule-1 (ICAM-1) in the Pathogenesis of asthmaScience, 1990
- Cooperative interactions of LFA-1 and Mac-1 with intercellular adhesion molecule-1 in facilitating adherence and transendothelial migration of human neutrophils in vitro.Journal of Clinical Investigation, 1989
- The major human rhinovirus receptor is ICAM-1Published by Elsevier ,1989